1982Journal of Antimicrobial ChemotherapyRequires access

Combination of ceftizoxime with azlocillin, mezlocillin, piperacillin and ticarcillin

Harold C. Neu

Open publisher page 16 citations

Abstract

Combination of two β -lactam agents has been used to enlarge the antibacterial spectrum of both the penicillin and cephalosporin components of the combination. However, some β-lactamase-stable cephalosporins by virtue of their induction of β-lactamases, cause destruction of the penicillins. Combination of ceftizoxime with azlocillin, meziocillin, piperacillin and ticarcillin showed synergy for 6.5–12%, an additive action for 9.8–25% and antagonism for only 1–3% of the 92 Enterobacteriaceae and Pseudomonas isolates tested. In contrast, combination of cefoxitin with the penicillins showed antagonism against 4–18% of isolates. Combination of ceftizoxime and oral antipseudomonas penicillins did not render strains resistant to the antipseudomonas penicillins susceptible. In no instance did the combination of ceftizoxime with an antipseudomonas penicillin cause an increase in minimal inhibitory concentration that would make the antagonism clinically significant.

About this research paper

What this paper is about

Combination of two β -lactam agents has been used to enlarge the antibacterial spectrum of both the penicillin and cephalosporin components of the combination. However, some β-lactamase-stable cephalosporins by virtue of their induction of β-lactamases, cause destruction of the penicillins. Combination of ceftizoxime with azlocillin, meziocillin, piperacillin and ticarcillin showed synergy for 6.5–12%, an additive action for 9.8–25% and antagonism for only 1–3% of the 92 Enterobacteriaceae and Pseudomonas isolates tested. In contrast, combination of cefoxitin with the penicillins showed antagonism against 4–18% of isolates. Combination of ceftizoxime and oral antipseudomonas penicillins did not render strains resistant to the antipseudomonas penicillins susceptible. In no instance did the combination of ceftizoxime with an antipseudomonas penicillin cause an increase in minimal inhibitory concentration that would make the antagonism clinically significant.

Why it matters

OpenAlex reports 16 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Combination of two β -lactam agents has been used to enlarge the antibacterial spectrum of both the penicillin and cephalosporin components of the combination. However, some β-lactamase-stable cephalosporins by virtue of their induction of β-lactamases, cause destruction of the penicillins. Combination of ceftizoxime with azlocillin, meziocillin, piperacillin and ticarcillin showed synergy for 6.5–12%, an additive action for 9.8–25% and antagonism for only 1–3% of the 92 Enterobacteriaceae and Pseudomonas isolates tested. In contrast, combination of cefoxitin with the penicillins showed antagonism against 4–18% of isolates. Combination of ceftizoxime and oral antipseudomonas penicillins did not render strains resistant to the antipseudomonas penicillins susceptible. In no instance did the combination of ceftizoxime with an antipseudomonas penicillin cause an increase in minimal inhibitory concentration that would make the antagonism clinically significant.

Key concepts: Mezlocillin, Azlocillin, Ceftizoxime, Piperacillin, Ticarcillin, Medicine, Lomefloxacin, Cephalosporin

Related papers

Back to paper searchBrowse research topicsOriginal source
Combination of ceftizoxime with azlocillin, mezlocillin, piperacillin and ticarcillin — Research Paper | ScholarLens